Literature DB >> 1479449

Excitotoxic acid lesions of the primate subthalamic nucleus result in reduced pallidal neuronal activity during active holding.

I Hamada1, M R DeLong.   

Abstract

1. To gain a better understanding of the pathophysiology of hemiballismus in primates, and to test directly the hypothesis that the subthalamopallidal projection is excitatory, we studied the effects of lesions of the subthalamic nucleus (STN) on neuronal activity in the globus pallidus (GP) of monkeys during performance of a motor behavioral task. 2. Animals were trained to position and hold a manipulandum to which torque pulses were applied, producing elbow flexion and extension. The activity of neurons in the external (GPe) and internal (GPi) segments of GP was recorded in two monkeys during task performance before and after STN lesions. The STN was lesioned by the fiber-sparing neurotoxins ibotenic acid and/or kainic acid. 3. After lesioning, the firing rate of neurons in both segments of GP, which was measured during the period of holding before torque application, was significantly decreased in both animals. The mean of discharge rates of GPi neurons decreased (P < 0.001) from 69.8 (n = 169, SD = 21.6) to 47.4 spikes/s (n = 180, SD = 22.6) after lesioning. The mean of discharge rates of GPe neurons decreased from 63.6 spikes/s (n = 218, SD = 25.1) before lesions to 41.0 spikes/s (n = 208, SD = 18.1) after lesioning. 4. These results provide further evidence that STN gives rise to a major excitatory input to both segments of the GP and support the hypothesis that dyskinesias result from decreased GPi output.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1479449     DOI: 10.1152/jn.1992.68.5.1859

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  24 in total

1.  Changing views of basal ganglia circuits and circuit disorders.

Authors:  Mahlon DeLong; Thomas Wichmann
Journal:  Clin EEG Neurosci       Date:  2010-04       Impact factor: 1.843

Review 2.  Pathophysiology of parkinsonism.

Authors:  Adriana Galvan; Thomas Wichmann
Journal:  Clin Neurophysiol       Date:  2008-05-07       Impact factor: 3.708

3.  Unilateral lesions of the globus pallidus: report of four patients presenting with focal or segmental dystonia.

Authors:  A Münchau; D Mathen; T Cox; N P Quinn; C D Marsden; K P Bhatia
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-10       Impact factor: 10.154

4.  Activity of neurons of the subthalamic nucleus in relation to motor performance in the cat.

Authors:  F Cheruel; J F Dormont; D Farin
Journal:  Exp Brain Res       Date:  1996-03       Impact factor: 1.972

Review 5.  Milestones in research on the pathophysiology of Parkinson's disease.

Authors:  Thomas Wichmann; Mahlon R DeLong; Jorge Guridi; Jose A Obeso
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

6.  Surgery for Parkinson's disease.

Authors:  J A Obeso; J Guridi; J A Obeso; M DeLong
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-01       Impact factor: 10.154

Review 7.  Pathological basal ganglia activity in movement disorders.

Authors:  T Wichmann; J O Dostrovsky
Journal:  Neuroscience       Date:  2011-06-22       Impact factor: 3.590

Review 8.  Deep Brain Stimulation for Movement Disorders of Basal Ganglia Origin: Restoring Function or Functionality?

Authors:  Thomas Wichmann; Mahlon R DeLong
Journal:  Neurotherapeutics       Date:  2016-04       Impact factor: 7.620

Review 9.  Update on models of basal ganglia function and dysfunction.

Authors:  Mahlon DeLong; Thomas Wichmann
Journal:  Parkinsonism Relat Disord       Date:  2009-12       Impact factor: 4.891

10.  Constraint-induced movement therapy results in increased motor map area in subjects 3 to 9 months after stroke.

Authors:  Lumy Sawaki; Andrew J Butler; Xiaoyan Leng; Peter A Wassenaar; Yousef M Mohammad; Sarah Blanton; K Sathian; Deborah S Nichols-Larsen; Steven L Wolf; David C Good; George F Wittenberg
Journal:  Neurorehabil Neural Repair       Date:  2008 Sep-Oct       Impact factor: 3.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.